1. Relations between Plasma von Willebrand Factor or Endothelin-1 and Restenosis following Carotid Artery Stenting.
- Author
-
Hua Yang, Jian-Xin Xu, Xiang-Zhi Kong, Zeng-Guang Ren, Zhang-Yong Xia, Huai-Qian Qu, and Le-Xin Wang
- Subjects
VON Willebrand disease ,ENDOTHELINS ,CORONARY restenosis ,SYMPTOMS ,CAROTID artery ,SURGICAL stents - Abstract
Objective: This study was designed to investigate the relation between plasma von Willebrand factor (VWF) or endothelin-1 (ET-1) and post-carotid artery stenting (CAS) restenosis. Materials and Methods: Plasma levels of VWF and ET-1 were measured in 61 patients (36 males, mean age 64.4 ± 6.8 years) before and after CAS. The mean follow-up time was 13.8 ± 1.7 months (range, 6-63). In-stent restenosis was defined as a >10% narrowing of the vascular lumen with or without ischemic symptoms following CAS. Results: In-stent restenosis was identified in 14 (23%) patients, including 3 with >50% restenosis. In the restenosis group, mean VWF and ET-1 levels at 2 weeks. 1 and 6 months after CAS were higher than the baseline levels (p < 0.05 or p < 0.01). Mean levels of VWF and ET-1 in the restenosis group were higher than in the non-restenosis group within 6 months after CAS (p < 0.05 or p < 0.01). Conclusion: Persistent elevation in plasma VWF and ET-1 within the first 6 months of CAS was found in patients with in-stent restenosis. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF